Search for: "Wyeth Pharmaceuticals" Results 421 - 440 of 976
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Oct 2010, 12:05 pm by Steve McConnell
Novartis Pharmaceuticals Corp., MID-L-1835-08-MT, Middlesex County. [read post]
18 Oct 2010, 9:29 am
Some fear that pharmaceutical firms will stop making vaccines due to the cost of defending design defect cases. [read post]
12 Oct 2010, 8:26 am by Joe Consumer
Pharmaceutical companies responded with a threat - they would stop making vaccines unless federal lawmakers shielded them from liability. [read post]
12 Oct 2010, 8:26 am by Joe Consumer
Pharmaceutical companies responded with a threat - they would stop making vaccines unless federal lawmakers shielded them from liability. [read post]
12 Oct 2010, 5:24 am by By DEALBOOK
Pfizer agreed to buy the maker of pain medication for $3.6 billion in cash, in the giant drug maker's first major deal since its blockbuster purchase of Wyeth last year. [read post]
6 Oct 2010, 4:22 am by Kelly
General Update on the Indo-E.U. trade dispute before the WTO (Spicy IP) Australia: Proceedings in other jurisdictions no excuse for delay: Wyeth v The Kennedy Institute of Rheumatology (Patentology) EU: Positive opinions on Paediatric Investigation Plans (The SPC Blog) EU: Guidelines for biosimilar antibodies in Europe due in November (Patent Docs) Netherlands: Court of Appeal of The Hague dismisses request to suspend execution of judgment in first instance: Sandoz v Leo… [read post]
2 Oct 2010, 8:43 am by Peter Rost
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
29 Sep 2010, 3:22 am by Seth
Plaintiffs sued pharmaceutical Wyeth in New York state court, alleging that their cancer was caused by Wyeth hormone replacement therapy. [read post]
27 Sep 2010, 9:29 am by Walter Olson
[New York Times; MI way back when] Tags: pharmaceuticals Related posts Wyeth v. [read post]
20 Sep 2010, 10:08 pm by Walter Olson
[Radley Balko] Tags: North Carolina, pharmaceuticals Related posts Wyeth v. [read post]
15 Sep 2010, 2:40 am by Kelly
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US: PHOSITA:… [read post]
7 Sep 2010, 6:10 pm by Kelly
Perrigo Co (IPBiz) Norvir (Ritonavir) – US: Abbott’s HIV/AIDS drug patents challenged by PUBPAT (IP Watchdog) ReFacto (Moroctocog) and Xyntha (Antihemophilic factor) – US: Novartis drops one of three patents from ReFacto/Xyntha suit against Wyeth (Patent Docs) Strattera (Atomoxetine) – US: CAFC grants injunction pending disposition of Lilly v Actavis Elizabeth (Patent Docs) Valcyte (Valganciclovir) – US: Ranbaxy settles patent dispute with Roche over Valcyte… [read post]
6 Sep 2010, 10:21 am by Steve McConnell
Novartis Pharmaceuticals Corp., 2010 U.S. [read post]
2 Sep 2010, 8:35 am by Stefanie Levine
Here is the latest  installment of Reexamination Requests from Scott M. [read post]
27 Aug 2010, 2:41 pm by Bexis
Ortho Pharmaceutical Corp., 209 Cal. [read post]